格隆汇8月25日丨中化化肥(00297.HK)宣布，张光艳已获委任为公司非执行董事，并将同时担任董事会 审核委员会成员，自2025年8月25日起生效。 ...

截至二零二五年六月三十日止六個月 財務摘要 1 （於百慕達註冊成立之有限公司） （股份代號：297） 中期業績公告 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不會就因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 SINOFERT HOLDINGS LIMITED 中化化肥控股有限公司 本集團始終牢記助力糧食安全、服務中國農民的使命責任，聚焦主責主業，堅定推進「生物+」戰略， 以科技創新為核心驅動，強化產業協同和加速商業轉化，提升渠道數字化能力，進一步提質增效， 經營效益及經營效率取得雙增長。 財務業績 截至二零二五年六月三十日止六個月，本集團實現營業額人民幣147.15億元，本公司股東應佔溢利 人民幣11.04億元，同比增長5.04%。 2 研究開發 ‧ 本期本集團營業額人民幣147.15億元，同比增長7.56% ‧ 本期本公司股東應佔溢利人民幣11.04億元，同比增長5.04% ‧ 本期每股基本盈利人民幣0.1572元，同比增長5.04% ‧ 董事會建議不宣派截至二零二五年六月三十日止六個月的中 ...

SINOFERT HOLDINGS LIMITED 中化化肥控股有限公司 （於百慕達註冊成立之有限公司） （股份代號：297） 董事名單與其角色和職能 中化化肥控股有限公司董事會（「董事會」）成員載列如下。 非執行董事 蘇賦先生（主席） 張光艷女士 執行董事 高明東先生 盧欣先生 孫寶源先生 董事會設立五個委員會。下表提供各董事會成員在該等委員會中所擔任的職位。 | | 委員會 | 審核委員會 | 薪酬委員會 | 提名委員會 | 企業管治 委員會 | 戰略委員會 | | --- | --- | --- | --- | --- | --- | --- | | 董事 | | | | | | | | 蘇賦 | | | | | | C | | 張光艷 | | M | | | | | | 王鐵林 | | | | | C | M | | 陳勝男 | | | | | M | M | | 王凌 | | | | M | M | M | | 高明東 | | M | M | C | | | | 盧欣 | | M | C | M | | M | | 孫寶源 | | C | M | M | | | 附註： C 有關委員會的主席 M 有 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該 等內容而引致之任何損失承擔任何責任。 SINOFERT HOLDINGS LIMITED 中化化肥控股有限公司 ( 於百慕達註冊成立之有限公司 ) (股份代號：297) 公告 中化化肥控股有限公司（「本公司」）董事會（「董事會」）宣佈，張光艷女士（「張女士」） 已獲委任為本公司非執行董事，並將同時擔任董事會審核委員會成員，自二零二五年八月二 十五日起生效。 張女士的簡歷如下： 張光艷女士，五十一歲，一九九六年七月畢業於對外經濟貿易大學國際貿易專業，獲經濟學 學士學位，並於二零一四年六月獲得對外經濟貿易大學企業管理專業管理學碩士學位。張女 士於一九九六年七月加入中化集團，曾任中國化工進出口總公司風險管理部總經理助理、中 國中化股份有限公司紀檢監察室主任助理兼一部經理、紀檢監察部（巡視辦）一室主任及紀 律檢查專員，以及本公司最終控股股東中國中化控股有限責任公司（「中國中化」）黨組巡 視辦巡視專員及副組長等。於二零零三年九月至二零一一年六月期間， ...

格隆汇8月12日丨中化化肥(00297.HK)宣布，公司将于2025年8月25日(星期一)举行董事会会议，藉以(其 中包括)讨论并批准公司及其附属公司截至2025年6月30日止六个月的未经审核中期业绩及其发布，以及 考虑派发中期股息(如有)。 ...

( 於百慕達註冊成立之有限公司 ) 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不會就因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 SINOFERT HOLDINGS LIMITED 中化化肥控股有限公司 代表董事會 中化化肥控股有限公司 主席 蘇賦 香港，二零二五年八月十二日 於本公告日期，本公司非執行董事為蘇賦先生（主席）；本公司執行董事為王鐡林先 生（首席執行官）、陳勝男女士及王凌女士；及本公司獨立非執行董事為高明東先 生、盧欣先生及孫寶源先生。 1 (股份代號：297) 公告 董事會召開日期 中化化肥控股有限公司（「本公司」）董事會（「董事會」）宣佈，本公司將於二零 二五年八月二十五日（星期一）舉行董事會會議，藉以（其中包括）討論並批准本公 司及其附屬公司截至二零二五年六月三十日止六個月的未經審核中期業績及其發佈， 以及考慮派發中期股息（如有）。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00297 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 80,000,000,000 | HKD | | 0.1 | HKD | | 8,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 80,000,000,000 | HKD | | 0.1 | HKD | | 8,000,000,000 | | 2. 股份分類 | 優先股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | ...

Core Viewpoint - A coalition of seven major potassium fertilizer distribution companies in China has issued an initiative to increase potassium fertilizer supply and reduce prices, aiming to bring fertilizer prices back to reasonable levels [1] Group 1: Industry Supply and Demand - The coalition includes China Agricultural Production Materials Group Co., Ltd., Sinochem Fertilizer Co., Ltd., China Chemical Construction Corporation, Huakan International Trade Co., Ltd., Zhejiang Agricultural Group Co., Ltd., Guangdong Tianhe Agricultural Materials Co., Ltd., and Heilongjiang Supply and Marketing Beifeng Agricultural Social Service Co., Ltd. [1] - The companies emphasize the need to correctly assess the current potassium fertilizer supply and demand situation, resist malicious speculation, and maintain market order [1] Group 2: Market Conditions - A meeting held on July 15 concluded that the domestic potassium fertilizer market supply is relatively sufficient during the non-agricultural demand peak season, and future imports of potassium fertilizer are expected to increase significantly [1] - The recent rise in potassium fertilizer prices is attributed to speculative activities, which have deviated significantly from the fundamental supply and demand dynamics [1]

截至7月14日收盘，中化化肥（00297.HK）报1.410港元，较上个交易日上涨2.92%，当日盘中最高价触 及1.420港元，创近一年新高。 资金流向方面，当日主力流入NaN万港元，流出NaN万港元，净流入1561.44万港元。 中化化肥控股有限公司(简称"中化化肥",前身为"中化香港控股有限公司")涵盖资源、研发、生产、分 销、农化服务全产业链。本公司于2005年7月成功收购ChinaFertilizer(Holdings)CompanyLimited及其附属 公司("化肥集团")后在香港联合交易所挂牌上市(股票代码:00297),是中国化肥行业首家在香港上市的企 业。中化化肥在国际化肥市场上具有重要影响力,是国际肥料工业协会(IFA)会员单位、国际植物营养研 究所(IPNI)全球17家理事单位之一。中化化肥拥有逾60年的化肥国际贸易经验和国际贸易关系网络实力, 是中国进口化肥的主渠道,为保障国内紧缺化肥资源供应、调剂余缺发挥骨干和建设性作用。中化化肥 拥有最齐全的大量元素、中微量元素肥料以及专用肥、缓控释肥、生物肥等新型肥料的研发、生产能 力。中化化肥在中国主要的农业省、农业县拥有自己建设的、国内最大 ...

Financial Performance - The company's revenue for 2024 was RMB 21,264,854, a decrease of 2.14% from RMB 21,728,120 in 2023[16] - Gross profit increased to RMB 2,543,838, up 12.54% from RMB 2,259,547 in the previous year[16] - Profit attributable to shareholders rose to RMB 1,061,480, representing a significant increase of 69.91% compared to RMB 625,549 in 2023[16] - Basic earnings per share improved to RMB 0.1511, up from RMB 0.0891 in the prior year[16] - Return on equity increased to 10.55%, compared to 6.52% in 2023, indicating enhanced profitability[16] - The company achieved a revenue of RMB 21.265 billion for the year ending December 31, 2024, with a net profit attributable to shareholders of RMB 1.061 billion, representing a year-on-year growth of 69.49%[58] - Excluding impairment losses related to Yangmei Plain Chemical Co., the adjusted net profit attributable to shareholders for the year was RMB 1.229 billion, a growth of 6.96% compared to RMB 1.149 billion for the previous year[59] - The segment profit for the fiscal year ending December 31, 2024, was RMB 1.38 billion, down from RMB 1.42 billion in the previous year, a decrease of about 3.06%[90][93] - The basic business segment reported a profit of RMB 645 million, a decrease of 4.9% compared to the previous year[90] - The growth business segment achieved a profit of RMB 347 million, a significant increase of 45.11% year-over-year, driven by a 10% increase in compound fertilizer sales and a 59% increase in high-end differentiated compound fertilizer sales[90] - The production business segment's profit was RMB 387 million, a decrease of 23% year-over-year, impacted by a significant drop in synthetic ammonia prices[90] - The net profit margin for the fiscal year ending December 31, 2024, was 4.99%, an increase of 2.11 percentage points compared to the previous year[94] Sales and Market Performance - In 2024, the company achieved a sales volume of 7.21 million tons and a revenue of RMB 21.265 billion, with a net profit of RMB 1.075 billion, representing a year-on-year growth of 57%[20] - The company's shareholder profit reached RMB 1.061 billion, marking a year-on-year increase of 69.49%[20] - The company launched 6 new or upgraded products, including "Huanfeng" and "Weidefeng," achieving a total research output of 1.285 million tons, with sales of Class A products like Lanlin and Kede Feng increasing by 55% year-on-year[60] - The company achieved a 12% year-on-year increase in phosphate fertilizer sales, with differentiated biological phosphate fertilizer sales reaching 250,000 tons, a 14% increase year-on-year[63] - The differentiated compound fertilizer sales for 2024 are projected to be 1.5 million tons, an increase of 160,000 tons year-on-year, with high-end biological products seeing a 59% year-on-year sales growth[64] - The total sales of specialty fertilizers exceeded 110,000 tons in 2024, a year-on-year increase of 20%, with soil health products achieving sales of 30,000 tons, up 11% year-on-year[65] - The company reported a revenue of RMB 410 million from collaborative plant protection in 2024, a 5% increase year-on-year, with a three-year compound growth rate of 17%[66] Research and Development - The company is committed to continuous research and development in crop nutrition products and related technologies[12] - The company launched the "Bio+" technology brand and achieved a research output conversion of 1.285 million tons, with Class A product sales increasing by 55% year-on-year[22] - The company’s research and development efforts are focused on the "Biological +" strategy, with 27 patents granted in key biotechnology areas, enhancing its technological foundation[60] - The company’s innovative "Root-Phosphorus Efficient Coupling Technology" was recognized as a major new agricultural technology in China for 2024, marking a significant achievement in its R&D efforts[47] - The company aims to enhance its integrated R&D capabilities in "nutrient efficiency, biological agents, and soil health" under its "Biological +" strategy[78] Strategic Initiatives - The company aims to lead in bio-fertilizer and soil health innovation, focusing on sustainable agricultural practices[11] - The company has established a comprehensive sales service network covering 95% of arable land in China[12] - Strategic partnerships with international suppliers have been formed to enhance product offerings and market reach[12] - The company signed a strategic cooperation memorandum with the American company for sustainable agricultural development and technology innovation[35] - The company aims to enhance operational management and provide green and efficient crop nutrition products while ensuring stable cash flow for investment decisions[23] - The company plans to celebrate its 20th anniversary in 2025 with a focus on the "Bio+" strategy and sustainable development[23] Environmental and Social Responsibility - The company maintained a 100% utilization rate of phosphogypsum for two consecutive years and received multiple awards for its environmental projects[22] - The company is committed to ensuring food security and supporting farmers' income growth as part of its social responsibility initiatives[78] - The company received the "Leading Environmental Project" award for its "Sinochem Changshan Low Carbon Environmental Comprehensive Management Project" at the 2024 ESG Leading Enterprises event[47] Governance and Management - The company has a strong governance structure with independent non-executive directors overseeing various committees, ensuring compliance and strategic direction[145][146][147] - The company emphasizes its commitment to corporate governance and strategic planning through the establishment of various committees[145][146] - The board of directors consists of seven members, including three executive directors, one non-executive director, and three independent non-executive directors[158] - The company has adopted the corporate governance code as per the listing rules, ensuring compliance and transparency in its operations[155] - The company has experienced a change in board composition, with Mr. Liu Hongsheng resigning as non-executive director and chairman, and Mr. Su Fu appointed as his successor[159] - The company has implemented a mechanism to ensure that the opinions and suggestions of independent non-executive directors are communicated to management for follow-up[164] Employee Development - The group employs approximately 4,371 full-time employees, with compensation structured to align employee interests with company performance and shareholder value[135] - A total of 21,565 training sessions were conducted, amounting to approximately 158,092 hours of training, covering various topics to enhance management skills and overall employee quality[190] - The group emphasizes employee development, with significant training initiatives aimed at improving core competitiveness[190] Financial Management and Risks - The company faces significant financial risks, including market risk, credit risk, and liquidity risk[127] - Market risk encompasses currency risk, interest rate risk, and other price risks, with management employing forward foreign exchange contracts to mitigate potential adverse impacts on financial performance[128] - The group has implemented robust management procedures for credit limits, payment terms, and overdue collections to prevent and control credit risk[130] - Liquidity risk management includes strengthening daily cash position management and maintaining sufficient cash and cash equivalents to meet operational and debt obligations[131]